Jennifer Myers has supported the life sciences industry since 2015, with experience spanning both early-stage biotech and public pharmaceutical companies. She currently serves as Administrator for Diapin. Since 2020, she has also served as Administrator for GeneToBe. She began her career as a Scientific Assistant at Gemphire Therapeutics, Inc., where she contributed from 2015 until the company's reverse merger with NeuroBo Pharmaceuticals, Inc. in December 2020. Following the merger, she continued her work in the field by consulting with NeuroBo Pharmaceuticals. Jennifer is currently pursuing a degree in Health Science with a focus on Nutrition.